| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $186K | -33.3% | -78.2% |
| Cost of Revenue | $1.9M | -80.1% | -41.7% |
| Gross Profit | -$1.7M | +81.5% | +29.1% |
| R&D Expense | $1.8M | +165.7% | -24.8% |
| SG&A Expense | $4.3M | -28.4% | +73.8% |
| Operating Income | -$11.3M | +63.9% | -18.3% |
| Net Income | -$10.8M | +65.0% | -19.3% |
| EPS (Basic) | $0.00 | +100.0% | — |
| EPS (Diluted) | $0.00 | +100.0% | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $1.7M | -16.2% | -92.2% |
| Accounts Receivable | $397K | +326.9% | +1002.8% |
| Inventory | $17.5M | +5.7% | -23.9% |
| Current Assets | $55.7M | -2.4% | +3.3% |
| Total Assets | $77.7M | -4.4% | -3.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.0M | — | — |
| Capital Expenditures | $108K | — | — |
| Investing Cash Flow | $12.8M | — | — |
| Financing Cash Flow | $58.0M | — | — |
| Free Cash Flow | -$42.1M | — | — |
| $13.5M |
| +5.6% |
| -9.9% |
| Total Liabilities | $17.9M | -1.4% | -22.6% |
| Stockholders' Equity | $59.9M | -5.2% | +4.7% |